Carl Zeiss Meditec OCT system receives 510(k) clearance
October 14th 2005Carl Zeiss Meditec Inc. announces that the FDA has granted 510(k) clearance for its Visante OCT. The device is a stand-alone, high-resolution optical coherence tomography (OCT) imaging system for the anterior segment of the eye, including the cornea, iris, angle, and the lens.
Accommodating IOL offers new square-edge design delivered with new injector system
October 14th 2005Eyeonics has developed the crystalens SE System (Square Edge System), a modified design of the original crystalens accommodating IOL, which offers a 360? square-edge optic to help prevent posterior capsule opacification (PCO).
Pegaptanib sodium therapy points to interesting avenues for future research
October 14th 2005Anti-vascular endothelial growth factor (VEGF) therapy has been validated as the foundation treatment for age-related macular degeneration (AMD), evidence-based medicine should drive practice patterns, combination therapies should improve results, early treatment of early disease is a better approach, and anti-VEGF therapies will have a wider role to play than solely in AMD, stated Lawrence Singerman, MD, Friday during the retina subspecialty day at the American Academy of Ophthalmology.
Fourier-based wavefront LASEK promising for enhancements in highly aberrated eyes
October 14th 2005Preliminary results from small studies suggest Fourier-based wavefront LASEK may provide a safe and effective method for enhancing highly aberrated eyes that have had previous RK or LASIK, said Marguerite B. McDonald, MD, clinical professor of ophthalmology, Tulane University, and director, Southern Vision Institute, New Orleans.
Evolution in wavefront-guided treatment yielding improved outcomes
October 14th 2005A number of incremental advances that have occurred in wavefront-guided treatment during the past year have added up to significantly enhanced outcomes of these customized procedures, said Capt. Steven C. Schallhorn, MD, director, cornea and refractive surgery, Naval Medical Center, San Diego.
No AMD progression following cataract extraction, study finds
October 14th 2005Cataract surgery does not seem to accelerate progression to neovascular age-related macular degeneration (AMD) in those patients who are at low-to-moderate risk for progression, reported Frederick Ferris III, MD, Friday during the retina subspecialty day at the American Academy of Ophthalmology meeting.
AREDS II to test refined AREDS formulation
October 14th 2005The Age-Related Eye Disease Study II (AREDS II) will begin soon after the AREDS ends in December 2005. The study aims to refine the findings of AREDS, which demonstrated that oral supplementation with high-dose antioxidant vitamin and minerals (vitamins C and E, beta-carotene, zinc, and copper) reduced the risk of advanced age-related macular degeneration (AMD) by 25%.
Leading-Edge Glaucoma Management
October 14th 2005Participants in a Friday evening CME Symposium at The Fairmount Chicago received an update on factors that influence early diagnosis and detection of progression and therefore are crucial to effective patient management. Moderator Robert N. Weinreb, MD, University of California, San Diego, and other speakers discussed recent advances in optic nerve evaluation and the impact of central corneal thickness (CCT) and other factors on IOP measurement.
Skew deviations distinguished from oblique muscle palsy
October 12th 2005Nashville, TN—Knowledge of skew deviations and their management has changed dramatically in recent years. Skew deviations occur more commonly than previously suspected and result from lesions in the vertical vestibular ocular reflex pathway.
Sildenafil use may be linked to NAION in men
October 12th 2005Editor's Note: Howard Pomeranz, MD, describes a possible association of sildenafil and non-arteritic anterior ischemic optic neuropathy (NAION). There are several compelling parts of the argument, including temporal relationship of symptoms to drug delivery, a suggestive rechallenge history, a biologically plausible mechanism of effect, and analogy from other cases.
Ocular toxoplasmosis common cause of ocular inflammation
October 12th 2005When and how do you use laboratory testing in patients with suspected toxoplasmic retinochoroiditis? What patients require no testing? When and how do you use testing of intraocular fluids? What approach should be taken in routine clinical practice?
Chicago this year's host to 2,000 AAO scientific sessions
October 12th 2005Chicago will play host to the 109th annual meeting of the American Academy of Ophthalmology (AAO). The main meeting will run from Sunday, Oct. 15 to Tuesday, Oct. 18, but it will be preceded by 2 full days of subspecialty presentations beginning on Friday, Oct. 14. All of the subspecialty day programs and scientific program sessions will be held at the McCormick Place Convention Center on Chicago's beautiful lakefront. On Wednesday, Oct. 19, from 8 a.m. to 5:30 p.m., "The Best of the Academy in Spanish 2005" will be held in the Imperial Ballroom at the Fairmont Chicago.
Modified prolate IOL good choice for piggybacking
October 1st 2005Edina, MN—When IOL piggybacking is needed, combining the modified prolate anterior surface IOL (Tecnis, AMO) with a conventional spherical IOL is a good option because it provides patients the added benefit of improved optical performance and better quality of vision, said Y. Ralph Chu, MD.
Stay involved by overseeing procedural coding for reimbursement
October 1st 2005Must ophthalmologists understand procedural coding? Perhaps a staffer or even a computer program could do the job? Unfortunately, the answer today is that physicians need to remain involved, understanding and then overseeing the process in their offices.
IOL optic capture offers stability without capsule bag fixation
October 1st 2005Washington, DC—If capsule bag fixation is not possible, cataract surgeons have several options for IOL optic capture depending on the particular surgical needs, explained Howard V. Gimbel, MD, MPH, professor and chairman, department of ophthalmology, Loma Linda University, Loma Linda, CA.
Modified prolate IOL good choice for piggybacking
October 1st 2005Edina, MN—When IOL piggybacking is needed, combining the modified prolate anterior surface IOL (Tecnis, AMO) with a conventional spherical IOL is a good option because it provides patients the added benefit of improved optical performance and better quality of vision, said Y. Ralph Chu, MD.
Visual acuity promising after unilateral IOL implantation
October 1st 2005Orlando—Visual acuity maturation was similar in infants and young children treated with IOLs or aphakic contact lenses for unilateral congenital and developmental unilateral cataracts, according to results of a small, prospective, single-center study.
Systemic, intravitreal therapy encouraging for neovascular AMD
October 1st 2005Montreal—Favorable functional and anatomic outcomes in eyes with subfoveal neovascular age-related macular degeneration (AMD) were reported following 24 weeks in an open-label, uncontrolled clinical trial using off-label, systemic and intravitreal therapy with bevacizumab (Avastin, Genentech), a humanized full-length monoclonal anti-VEGF antibody.
Intravitreal triamcinolone helps macular diseases
October 1st 2005Montreal—Intravitreal triamcinolone acetonide (Kenalog, Bristol-Myers Squibb) is effective in the treatment of macular diseases but is associated with complications such as ocular hypertension, endophthalmitis, intraocular inflammation, and progression of cataract. While the long-term effects of the drug still need to be determined, the drug appears to be safe for treating macular diseases.
Age, family history primary factors in development of AMD
October 1st 2005Fort Lauderdale, FL—Numerous factors have been studied to determine an association with the development of age-related macular degeneration (AMD), according to Barbara Klein, MD, MPH. Family history, however, is by far the factor that stands out among the crowded arena of suspects. She reported why this is the case at the annual meeting of the Association for Research in Vision and Ophthalmology.
Minimally invasive transconjunctival surgery has advantages
October 1st 2005Montreal—Twenty-three gauge sutureless transconjunctival pars plana vitrectomy is effective for certain diseases of the posterior segment. The technique has the advantages of minimally invasive transconjunctival surgery without some of the limitations associated with 25-gauge surgery, reported Reza Iranmanesh, MD.
Confocal microscopy measures corneal nerve density
October 1st 2005Fort Lauderdale, FL—Confocal microscopy allows corneal nerve density to be measured in vivo, which has been especially helpful in identifying dramatic decreases in the nerve densities after PRK and LASIK. Using this technology, investigators can measure the increases in the densities over time following the surgeries. There are, however, artifacts that may interfere with microscopy results that must be controlled, according to William Bourne, MD.
Brazilian researchers seek to define effects of ortho-k
October 1st 2005Washington, DC—Reduction in myopia, central corneal flattening, and improvement of uncorrected visual acuity (UCVA) occur rapidly after the initiation of orthokeratology (ortho-k), but this modality also appears to result in changes in higher-order aberrations and corneal pachymetry, reported Iane G. Stillitano, MD, at the World Cornea Congress V.